Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, evaluator-blind, vehicle controlled, parallel group study to explore the effects of the anti-inflammatory drug prednisolone in a TLR7 challenge model with imiquimod in healthy volunteers

Next Previous
Trial Profile

A randomized, evaluator-blind, vehicle controlled, parallel group study to explore the effects of the anti-inflammatory drug prednisolone in a TLR7 challenge model with imiquimod in healthy volunteers

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Imiquimod (Primary) ; Prednisolone (Primary)
  • Indications Inflammation; Skin disorders
  • Focus Adverse reactions; Pharmacodynamics

Most Recent Events

  • 12 Sep 2021 This trial has been completed in Netherlands as per European Clinical Trials Database record.
  • 06 Aug 2020 Planned number of patients changed from 24 to 60.
  • 20 Apr 2020 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top